Alkermes (ALKS) Inventory Average (2011 - 2026)
Alkermes' (ALKS) quarterly Inventory Average came in at $266.7 million in Q1 2026, up 45.59% year-on-year from $183.2 million in Q1 2025, and up 37.59% on a QoQ basis from $193.8 million in Q4 2025.
Alkermes (ALKS) Inventory Average (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Inventory Average data on file, last reported at $266.7 million in Q1 2026.
- On a quarterly basis, Inventory Average rose 45.59% year-over-year to $266.7 million in Q1 2026; TTM through Mar 2026 was $266.7 million, a 45.59% increase from a year earlier, with the FY2025 full-year figure at $189.8 million, up 2.77% from the prior year.
- Inventory Average for Q1 2026 stood at $266.7 million, up from $193.8 million in the prior quarter.
- Over the last five years, Inventory Average for ALKS reached as high as $266.7 million in Q1 2026 and fell as low as $152.6 million in Q1 2022.
- Historically, Inventory Average has averaged $187.3 million across 5 years, with a median of $187.7 million in 2025.
- Across the five-year window, Inventory Average dropped 4.8% in 2025 and jumped 45.59% in 2026, its largest moves.
- Year by year, Inventory Average stood at $173.9 million in 2022, then grew by 8.88% to $189.3 million in 2023, then retreated by 1.22% to $187.0 million in 2024, then gained by 3.65% to $193.8 million in 2025, then jumped by 37.59% to $266.7 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $266.7 million in Q1 2026, $193.8 million in Q4 2025, and $191.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 266.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.66 Mn |
| Dec 31, 2025 | 193.81 Mn |
| Sep 30, 2025 | 191.46 Mn |
| Jun 30, 2025 | 187.68 Mn |
| Mar 31, 2025 | 183.16 Mn |
| Dec 31, 2024 | 186.99 Mn |
| Sep 30, 2024 | 192.91 Mn |
| Jun 30, 2024 | 196.55 Mn |
| Mar 31, 2024 | 192.39 Mn |
| Dec 31, 2023 | 189.30 Mn |
| Sep 30, 2023 | 190.78 Mn |
| Jun 30, 2023 | 187.18 Mn |
| Mar 31, 2023 | 183.20 Mn |
| Dec 31, 2022 | 173.86 Mn |
| Sep 30, 2022 | 160.95 Mn |
| Jun 30, 2022 | 155.20 Mn |
| Mar 31, 2022 | 152.56 Mn |
| Dec 31, 2021 | 144.52 Mn |
| Sep 30, 2021 | 137.39 Mn |
| Jun 30, 2021 | 135.13 Mn |